image
Basic Materials - Chemicals - Specialty - NASDAQ - US
$ 1.13
-2.59 %
$ 87.2 M
Market Cap
-1.4
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one ALTO stock under the worst case scenario is HIDDEN Compared to the current market price of 1.13 USD, Alto Ingredients, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one ALTO stock under the base case scenario is HIDDEN Compared to the current market price of 1.13 USD, Alto Ingredients, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one ALTO stock under the best case scenario is HIDDEN Compared to the current market price of 1.13 USD, Alto Ingredients, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ALTO

image
$2.0$2.0$1.8$1.8$1.6$1.6$1.4$1.4$1.2$1.2$1.0$1.0$0.8$0.8$0.6$0.6Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
965 M REVENUE
-21.07%
-51.7 M OPERATING INCOME
-116.68%
-59 M NET INCOME
-110.62%
-3.52 M OPERATING CASH FLOW
-15.99%
-13.5 M INVESTING CASH FLOW
59.23%
7.72 M FINANCING CASH FLOW
10.87%
227 M REVENUE
-4.15%
-9 M OPERATING INCOME
77.06%
-11.7 M NET INCOME
72.00%
-18.2 M OPERATING CASH FLOW
-86.22%
-7.81 M INVESTING CASH FLOW
-511.11%
17 M FINANCING CASH FLOW
93.52%
Balance Sheet Alto Ingredients, Inc.
image
Current Assets 153 M
Cash & Short-Term Investments 35.5 M
Receivables 58.2 M
Other Current Assets 59.4 M
Non-Current Assets 248 M
Long-Term Investments 0
PP&E 235 M
Other Non-Current Assets 13 M
8.84 %14.50 %14.80 %58.61 %3.24 %Total Assets$401.4m
Current Liabilities 57.8 M
Accounts Payable 20.4 M
Short-Term Debt 4.85 M
Other Current Liabilities 32.6 M
Non-Current Liabilities 119 M
Long-Term Debt 110 M
Other Non-Current Liabilities 8.75 M
11.55 %18.47 %62.26 %4.96 %Total Liabilities$176.4m
EFFICIENCY
Earnings Waterfall Alto Ingredients, Inc.
image
Revenue 965 M
Cost Of Revenue 956 M
Gross Profit 9.72 M
Operating Expenses 61.4 M
Operating Income -51.7 M
Other Expenses 7.31 M
Net Income -59 M
1b1b800m800m600m600m400m400m200m200m00(200m)(200m)965m(956m)10m(61m)(52m)(7m)(59m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
1.01% GROSS MARGIN
1.01%
-5.35% OPERATING MARGIN
-5.35%
-6.11% NET MARGIN
-6.11%
-26.21% ROE
-26.21%
-14.69% ROA
-14.69%
-14.87% ROIC
-14.87%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Alto Ingredients, Inc.
image
80m80m60m60m40m40m20m20m00(20m)(20m)(40m)(40m)(60m)(60m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -59 M
Depreciation & Amortization 24.4 M
Capital Expenditures -11.1 M
Stock-Based Compensation 4.36 M
Change in Working Capital 9.96 M
Others 11.7 M
Free Cash Flow -14.6 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Alto Ingredients, Inc.
image
ALTO has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 17
6. Ownership
Insider Ownership Alto Ingredients, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
100 K USD 3
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Alto Neuroscience Presents Data at the 2025 American Society of Clinical Psychopharmacology Annual Meeting Reinforcing Safety and Tolerability Profile for ALTO-300 in Major Depressive Disorder MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced a presentation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, in Scottsdale, Arizona, held May 27-30, 2025. ALTO-300, also known as agomelatine, is an oral, small molecule designed to act as a melatonin agonist and 5-HT2C antagonist be. businesswire.com - 3 weeks ago
Alto Ingredients, Inc. (ALTO) Q1 2025 Earnings Call Transcript Alto Ingredients, Inc. (NASDAQ:ALTO ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Kirsten Chapman - Investor Relations, Alliance Advisors IR Bryon McGregor - President & Chief Executive Officer Rob Olander - Chief Financial Officer Conference Call Participants Sameer Joshi - H.C. Wainwright Operator Good day, and welcome to the Alto Ingredients First Quarter 2025 Financial Results Conference Call. seekingalpha.com - 1 month ago
Alto Ingredients (ALTO) Reports Q1 Loss, Tops Revenue Estimates Alto Ingredients (ALTO) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.17 per share a year ago. zacks.com - 1 month ago
Alto Ingredients, Inc. Reports First Quarter 2025 Results - Beverage-grade Liquid CO2 Processor Acquisition and Corporate Reorganization  Deliver Improved Year-over-Year Gross Margin and Adjusted EBITDA - globenewswire.com - 1 month ago
Alto Ingredients, Inc. to Release First Quarter 2025 Financial Results on May 7, 2025 PEKIN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its first quarter 2025 financial results after the close of market on Wednesday, May 7, 2025. globenewswire.com - 1 month ago
Alto Ingredients, Inc. Directors to Not Stand for Reelection PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announced that two long-standing directors, Douglas L. Kieta and Michael D. Kandris, have decided they will not stand for reelection to the Alto Ingredients Board of Directors at the company's 2025 Annual Meeting of Stockholders, scheduled for June 25, 2025. globenewswire.com - 3 months ago
Alto Ingredients, Inc. Enters into Letter Agreement with Bradley L. Radoff and Michael Torok PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announced that it has entered into a letter agreement (the “Letter Agreement”) with Bradley L. Radoff and Michael Torok (collectively with their affiliates, the “Radoff/Torok Group”), under which the Radoff/Torok Group has agreed that during the period commencing on the date of the Letter Agreement until the date that is the earlier to occur of (i) thirty (30) days prior to the deadline for delivery of notice under the Company's Amended and Restated Bylaws for the nomination of director candidates for election to the Board of Directors (the “Board”) at Alto Ingredients, Inc.'s (the “Company”) 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) or (ii) one hundred twenty (120) days prior to the first anniversary of the 2025 Annual Meeting of Stockholders of the Company, currently scheduled for June 25, 2025 (the “Standstill Period”), at each annual or special meeting of the stockholders of the Company, the Radoff/Torok Group will cause all shares of the Company's common stock beneficially owned by it in favor of all directors nominated by the Board for election and otherwise in accordance with the recommendations of the Board, and against the election of any director nominee not so recommended by the Board. globenewswire.com - 3 months ago
Alto Ingredients, Inc. (ALTO) Q4 2024 Earnings Call Transcript Alto Ingredients, Inc. (NASDAQ:ALTO ) Q4 2024 Earnings Conference Call March 5, 2025 5:00 PM ET Company Participants Kirsten Chapman - IR, Alliance Advisors IR Bryon McGregor - President and CEO Rob Olander - CFO Conference Call Participants Sameer Joshi - H.C. Wainwright Eric Stine - Craig-Hallum Operator Good evening, and welcome to the Alto Ingredients Fourth Quarter and Year-End 2024 Financial Results Conference Call. seekingalpha.com - 3 months ago
Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2024 Results - Implemented Cost Savings Expected to Yield Approximately $8 Million Annually - - Integrated Accretive Acquisition of a Beverage-grade Liquid CO 2 Processor - - Considering Asset Sales, a Merger or Other Strategic Transactions - globenewswire.com - 3 months ago
Alto Ingredients, Inc. to Present in the 37th Annual Roth Conference PEKIN, Ill., March 04, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that management plans to participate at the 37th Annual Roth Conference on March 16th-18t h. The conference is being held at The Laguna Cliffs Marriott in Dana Point, CA globenewswire.com - 3 months ago
Alto Ingredients, Inc. to Release Fourth Quarter and Year-end 2024 Financial Results on March 5, 2025 PEKIN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its fourth quarter and year-end 2024 financial results after the close of market on Wednesday, March 5, 2025. globenewswire.com - 3 months ago
Alto Ingredients Could Soon Have The Right Recipe For A Rebound Alto Ingredients Could Soon Have The Right Recipe For A Rebound seekingalpha.com - 3 months ago
8. Profile Summary

Alto Ingredients, Inc. ALTO

image
COUNTRY US
INDUSTRY Chemicals - Specialty
MARKET CAP $ 87.2 M
Dividend Yield 0.37%
Description Alto Ingredients, Inc. produces and markets specialty alcohols and essential ingredients in the United States. The company operates in three segments: Marketing and Distribution, Pekin Production, and Other Production. It offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners for health, home, and beauty markets; grain neutral spirits used in alcoholic beverages, flavor extracts, and vinegar, as well as corn germ used in corn oils and carbon dioxide for food and beverage markets; and essential ingredients include dried yeast, corn gluten meal, corn gluten feed, distillers grains, and liquid feed for commercial animal feed and pet food applications. The company also provides fuel-grade ethanol used as transportation fuel and distillers corn oil used as a biodiesel feedstock, as well as fuel-grade ethanol produced by third parties. In addition, it offers transportation, storage, and delivery services through third-party service providers. The company sells ethanol to integrated oil companies and gasoline marketers; essential ingredient feed products to dairies and feedlots; and corn oil to poultry and biodiesel customers. It operates five alcohol production facilities, including three plants in the Midwestern states of Illinois; and two facilities located in the Western states of Oregon and Idaho. The company was formerly known as Pacific Ethanol, Inc. and changed its name to Alto Ingredients, Inc. in January 2021. Alto Ingredients, Inc. was founded in 2003 and is headquartered in Pekin, Illinois.
Contact 1300 South Second Street, Pekin, IL, 61554 https://www.altoingredients.com
IPO Date March 24, 2005
Employees 393
Officers Mr. Todd E. Benton Chief Operating Officer Mr. Ed Baker Vice President of Human Resources Mr. Bryon T. McGregor Chief Executive Officer, President & Director Mr. James R. Sneed CPA Vice President & Chief Commercial Officer Mr. Robert R. Olander Chief Financial Officer Ms. Auste M. Graham J.D. Chief Legal Officer & Secretary